ZBNA
XENE icon

Zions Bancorporation, National Association’s Xenon Pharmaceuticals XENE Stock Holding History

Zions Bancorporation, National Association’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.9K Buy
347
+42
+14% +$2.33K ﹤0.01% 767
2026
Q1 		$17.7K Buy
305
+70
+30% +$3.23K ﹤0.01% 767
2025
Q4 		$10.5K Buy
+235
New +$9.87K ﹤0.01% 836

Other funds holding XENE

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Zions Bancorporation, National Association's XENE Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Xenon Pharmaceuticals (XENE) stake by 14% in Q2 2026, buying an estimated $2.33K and bringing the position to 347 shares worth $20.9K. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Zions Bancorporation, National Association first reported a position in XENE in Q4 2025 and has held it in 3 quarters since. 52 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Zions Bancorporation, National Association held 347 shares of Xenon Pharmaceuticals worth $20.9K as of Q2 2026.
  • Zions Bancorporation, National Association bought 42 Xenon Pharmaceuticals shares in Q2 2026, an estimated $2.33K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #767 holding.
  • Zions Bancorporation, National Association first reported a position in Xenon Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 52 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.